iwNHL 2018 day 1 highlights: T-cells, biomarkers & personalized medicine
Catherine Bollard et al.
MMRF updates from ASH 2017: CoMMpass study, transplant outcomes and the molecular profiling protocol
The future is bright for hematological oncology: promising areas for 2018 and beyond
COMy 2017: Day 1 discussion on progress in multiple myeloma, patient advocacy and drug costs
Arnon Nagler et al.
Progress in acute myeloid leukemia treatment – collaborating to develop targeted therapies